Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An Assessment of Circulating Chromogranin A as a Biomarker of Bronchopulmonary Neuroendocrine Neoplasia: A Systematic Review and Meta-Analysis
Anna Malczewska, Mark Kidd, Somer Matar, et al.
Neuroendocrinology (2019) Vol. 110, Iss. 3-4, pp. 198-216
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

A meta-analysis of the accuracy of a neuroendocrine tumor mRNA genomic biomarker (NETest) in blood
K. Öberg, Andrea Califano, Jonathan Strosberg, et al.
Annals of Oncology (2020) Vol. 31, Iss. 2, pp. 202-212
Open Access | Times Cited: 104
Update of the diagnostic and therapeutic guidelines for gastro-entero-pancreatic neuroendocrine neoplasms (recommended by the Polish Network of Neuroendocrine Tumours) [Aktualizacja zaleceń ogólnych dotyczących postępowania diagnostyczno-terapeutycznego w nowotworach neuroendokrynnych układu pokarmowego (rekomendowane przez Polską Sieć Guzów Neuroendokrynnych)]
Beata Kos‐Kudła, Wanda Fołtyn, Anna Malczewska, et al.
Endokrynologia Polska (2022) Vol. 73, Iss. 3, pp. 387-454
Open Access | Times Cited: 35
The clinical applications of a multigene liquid biopsy (NETest) in neuroendocrine tumors
Anna Malczewska, Beata Kos‐Kudła, Mark Kidd, et al.
Advances in Medical Sciences (2019) Vol. 65, Iss. 1, pp. 18-29
Open Access | Times Cited: 52
Diagnostic work-up and advancement in the diagnosis of gastroenteropancreatic neuroendocrine neoplasms
Apostolos Koffas, Alexandros Giakoustidis, Apostolis Papaefthymiou, et al.
Frontiers in Surgery (2023) Vol. 10
Open Access | Times Cited: 14
An Overview of Circulating Biomarkers in Neuroendocrine Neoplasms: A Clinical Guide
Michele Bevere, Francesca Masetto, Maria Elena Carazzolo, et al.
Diagnostics (2023) Vol. 13, Iss. 17, pp. 2820-2820
Open Access | Times Cited: 14
The Surgical Management of Lung Neuroendocrine Neoplasms
Patrick Soldath, René Horsleben Petersen
Cancers (2023) Vol. 15, Iss. 6, pp. 1695-1695
Open Access | Times Cited: 13
Circulating Neuroendocrine Tumor Biomarkers: Past, Present and Future
Paweł Komarnicki, Jan Musiałkiewicz, Alicja Stańska, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 19, pp. 5542-5542
Open Access | Times Cited: 21
Circulating Neuroendocrine Gene Transcripts (NETest): A Postoperative Strategy for Early Identification of the Efficacy of Radical Surgery for Pancreatic Neuroendocrine Tumors
Stefano Partelli, Valentina Andreasi, Francesca Muffatti, et al.
Annals of Surgical Oncology (2020) Vol. 27, Iss. 10, pp. 3928-3936
Closed Access | Times Cited: 30
Selective application of neuroendocrine markers in the diagnosis and treatment of small cell lung cancer
Jing Du, Yanchun Li, Lei Wang, et al.
Clinica Chimica Acta (2020) Vol. 509, pp. 295-303
Closed Access | Times Cited: 27
Prospective Evaluation of the NETest as a Liquid Biopsy for Gastroenteropancreatic and Bronchopulmonary Neuroendocrine Tumors: An ENETS Center of Excellence Experience
Anna Malczewska, Magdalena Witkowska, Monika Wójcik-Giertuga, et al.
Neuroendocrinology (2020) Vol. 111, Iss. 4, pp. 304-319
Closed Access | Times Cited: 26
Established and novel circulating neuroendocrine tumor biomarkers for diagnostic, predictive and prognostic use
Marina Tsoli, Anna Koumarianou, Anna Angelousi, et al.
Best Practice & Research Clinical Endocrinology & Metabolism (2023) Vol. 37, Iss. 5, pp. 101785-101785
Closed Access | Times Cited: 8
Utility of a ready-to-use PCR system for neuroendocrine tumor diagnosis
Mark Kidd, Ignat Drozdov, Somer Matar, et al.
PLoS ONE (2019) Vol. 14, Iss. 6, pp. e0218592-e0218592
Open Access | Times Cited: 25
Diagnostic and therapeutic advances in neuroendocrine tumours
Martyn Caplin, Gowri M. Ratnayake
Nature Reviews Endocrinology (2020) Vol. 17, Iss. 2, pp. 81-82
Closed Access | Times Cited: 21
MiRNA Expression in Neuroendocrine Neoplasms of Frequent Localizations
А. А. Коротаева, Danzan Mansorunov, Н. В. Апанович, et al.
Non-Coding RNA (2021) Vol. 7, Iss. 3, pp. 38-38
Open Access | Times Cited: 17
Predictive Factors for Resistant Disease with Medical/Radiologic/Liver-Directed Anti-Tumor Treatments in Patients with Advanced Pancreatic Neuroendocrine Neoplasms: Recent Advances and Controversies
Lingaku Lee, Irene Ramos-Álvarez, Robert T. Jensen
Cancers (2022) Vol. 14, Iss. 5, pp. 1250-1250
Open Access | Times Cited: 11
Neuroendocrine Neoplasms
Ajitha Ramesh, Aniruddha Chatterjee, Rathan M. Subramaniam
PET Clinics (2023) Vol. 18, Iss. 2, pp. 161-168
Closed Access | Times Cited: 5
Perspectives on the diagnostic, predictive and prognostic markers of neuroendocrine neoplasms (Review)
Oana Ciobanu, Sorina Martin, Simona Fica
Experimental and Therapeutic Medicine (2021) Vol. 22, Iss. 6
Open Access | Times Cited: 12
True Chromogranin A concentrations in plasma from patients with small intestinal neuroendocrine tumours
Jens F. Rehfeld, Kasper Broedbaek, Jens P. Goetze, et al.
Scandinavian Journal of Gastroenterology (2020) Vol. 55, Iss. 5, pp. 565-573
Closed Access | Times Cited: 12
Molecular markers in cancer
Ejaj Ahmad, Asgar Ali, Nimisha, et al.
Clinica Chimica Acta (2022) Vol. 532, pp. 95-114
Closed Access | Times Cited: 8
Molecular identification of bronchopulmonary neuroendocrine tumours and neuroendocrine genotype in lung neoplasia using the NETest liquid biopsy
Pier Luigi Filosso, Kjell Öberg, Anna Malczewska, et al.
European Journal of Cardio-Thoracic Surgery (2020) Vol. 57, Iss. 6, pp. 1195-1202
Open Access | Times Cited: 9
Plasma Progastrin-Releasing Peptide and Chromogranin A Assays for Diagnosing and Monitoring Lung Well-Differentiated Neuroendocrine Tumors: A Brief Report
Benjamin Nisman, Kira Oleinikov, Hovav Nechushtan, et al.
Journal of Thoracic Oncology (2022) Vol. 18, Iss. 3, pp. 369-376
Open Access | Times Cited: 6
Use of tissue chromogranin A as chronic and acute stress marker in fish
Marcelino Herrera, Natalia Salamanca, J.F. Ferrer, et al.
Aquaculture (2022) Vol. 565, pp. 739120-739120
Open Access | Times Cited: 5
Functional and Molecular Characters of Cancer Stem Cells Through Development to Establishment
Said M. Afify, Ghmkin Hassan, Hiroko Ishii, et al.
Advances in experimental medicine and biology (2022), pp. 83-101
Closed Access | Times Cited: 4
<p>Clinical Evaluation of Everolimus in the Treatment of Neuroendocrine Tumors of the Lung: Patient Selection and Special Considerations. A Systematic and Critical Review of the Literature</p>
Marta Peri, Nicola Fazio
Lung Cancer Targets and Therapy (2020) Vol. Volume 11, pp. 41-52
Open Access | Times Cited: 5
Evaluating Prognosis of Gastrointestinal Metastatic Neuroendocrine Tumors: Constructing a Novel Prognostic Nomogram Based on NETPET Score and Metabolic Parameters from PET/CT Imaging
Yifan Liu, Ruizhe Cui, Zhixiong Wang, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 3, pp. 373-373
Open Access
Page 1 - Next Page

Scroll to top